ID: ALA2003405

Max Phase: Preclinical

Molecular Formula: C21H20F3N3O

Molecular Weight: 387.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCC(=O)c1ccc(NCc2c[nH]nc2-c2ccc(C(F)(F)F)cc2)cc1

Standard InChI:  InChI=1S/C21H20F3N3O/c1-2-3-19(28)14-6-10-18(11-7-14)25-12-16-13-26-27-20(16)15-4-8-17(9-5-15)21(22,23)24/h4-11,13,25H,2-3,12H2,1H3,(H,26,27)

Standard InChI Key:  NTMHUKHTTYWAIC-UHFFFAOYSA-N

Associated Targets(Human)

Tyrosine-protein kinase FRK 2284 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CaM kinase II gamma 1752 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CaM kinase II beta 1626 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CaM kinase II delta 2813 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 387.41Molecular Weight (Monoisotopic): 387.1558AlogP: 5.69#Rotatable Bonds: 7
Polar Surface Area: 57.78Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.82CX LogP: 5.09CX LogD: 5.09
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -1.43

References

1. PubChem BioAssay data set, 

Source

Source(1):